WellPoint Stock Rating Reaffirmed by Credit Suisse (WLP)
WellPoint (NYSE:WLP)‘s stock had its “neutral” rating reiterated by investment analysts at Credit Suisse in a note issued to investors on Wednesday. They currently have a $111.00 target price on the stock, up from their previous target price of $109.00. Credit Suisse’s target price indicates a potential upside of 2.15% from the company’s current price.
Shares of WellPoint (NYSE:WLP) traded up 1.56% on Wednesday, hitting $110.35. 1,952,726 shares of the company’s stock traded hands. WellPoint has a 1-year low of $81.46 and a 1-year high of $116.50. The stock’s 50-day moving average is $111.0 and its 200-day moving average is $100.9. The company has a market cap of $30.263 billion and a price-to-earnings ratio of 14.39.
WellPoint (NYSE:WLP) last released its earnings data on Wednesday, July 30th. The company reported $2.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.25 by $0.19. The company had revenue of $18.23 billion for the quarter, compared to the consensus estimate of $18.25 billion. During the same quarter in the previous year, the company posted $2.60 earnings per share. The company’s revenue for the quarter was up 4.2% on a year-over-year basis. On average, analysts predict that WellPoint will post $8.69 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Thursday, September 25th. Stockholders of record on Wednesday, September 10th will be paid a dividend of $0.4375 per share. This represents a $1.75 annualized dividend and a dividend yield of 1.61%. The ex-dividend date is Monday, September 8th.
In other WellPoint news, CFO Wayne S. Deveydt sold 30,000 shares of WellPoint stock on the open market in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $110.95, for a total value of $3,328,500.00. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Several other analysts have also recently commented on the stock. Analysts at BMO Capital Markets raised their price target on shares of WellPoint from $103.00 to $111.00 in a research note on Tuesday, August 5th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of WellPoint in a research note on Thursday, July 31st. They now have a $118.00 price target on the stock. Finally, analysts at Barclays reiterated an “equal weight” rating on shares of WellPoint in a research note on Thursday, July 31st. They now have a $120.00 price target on the stock, up previously from $110.00. Fourteen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. WellPoint has a consensus rating of “Hold” and a consensus target price of $117.89.
WellPoint, Inc (NYSE:WLP) is a health benefit company in terms of medical membership in the United States.
Receive News & Ratings for WellPoint Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WellPoint Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.